KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Neogenomics (NEO) Gross Profit (2016 - 2026)

Neogenomics filings provide 17 years of Gross Profit readings, the most recent being $80.9 million for Q1 2026.

  • On a quarterly basis, Gross Profit rose 10.4% to $80.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $321.9 million, a 8.07% increase, with the full-year FY2025 number at $314.3 million, up 8.34% from a year prior.
  • Gross Profit hit $80.9 million in Q1 2026 for Neogenomics, down from $83.3 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $83.3 million in Q4 2025 to a low of $38.2 million in Q1 2022.
  • Median Gross Profit over the past 5 years was $67.6 million (2023), compared with a mean of $65.8 million.
  • Biggest five-year swings in Gross Profit: decreased 17.07% in 2022 and later skyrocketed 43.37% in 2023.
  • Neogenomics' Gross Profit stood at $56.8 million in 2022, then increased by 18.94% to $67.6 million in 2023, then rose by 14.31% to $77.3 million in 2024, then grew by 7.88% to $83.3 million in 2025, then fell by 2.97% to $80.9 million in 2026.
  • The last three reported values for Gross Profit were $80.9 million (Q1 2026), $83.3 million (Q4 2025), and $80.4 million (Q3 2025) per Business Quant data.